Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar;54(3):225-42.
doi: 10.1007/s40262-015-0241-y.

Drug transporters in the central nervous system

Affiliations
Free article
Review

Drug transporters in the central nervous system

Bruno Stieger et al. Clin Pharmacokinet. 2015 Mar.
Free article

Abstract

Drug targets in the central nervous system (CNS) are numerous and important for drug therapy, e.g., of epilepsy or pain. Drugs and other xenobiotics as well as nutrients cannot freely cross the blood-brain barrier or freely enter cells across plasma membranes and therefore require transport systems. This overview summarizes the current knowledge on the expression of drug transporters in barriers shielding the CNS from the systemic circulation and as such controlling the pharmacokinetics of drugs in the CNS. The main drug transporter families covered are SLCO, SCL22A, ABCB, and ABCC, as genes of these families code for numerous drug transporters. While knowledge on messenger RNA expression in humans, rats, and mice is remarkable, there is clearly a gap in knowledge on the subcellular expression of transporters in specific cells in the CNS and in the barriers shielding the CNS from the systemic circulation. Recent methodologic developments including synthesis of drugs and endogenous substances for imaging will in the future allow the investigation of the function and physiologic role of transporters in the CNS including difficult-to-access systems such as the choroid plexus.

PubMed Disclaimer

References

    1. Xenobiotica. 2008 Jul;38(7-8):995-1021 - PubMed
    1. Adv Pharmacol. 2014;71:45-111 - PubMed
    1. Drug Discov Today. 2011 Aug;16(15-16):704-14 - PubMed
    1. Mol Aspects Med. 2013 Apr-Jun;34(2-3):742-52 - PubMed
    1. Drug Metab Dispos. 2012 Jun;40(6):1164-9 - PubMed

Publication types

MeSH terms

Substances